Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

FLYING NURSES ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   11.3% 10.5% 10.8% 2.5% 9.1% 2.6% 12.7% 12.7%   Credit score (0-100)   23 25 22 61 26 60 18 18   Credit rating   BB BB BB BBB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,847 1,688 1,011 2,332 823 1,817 0.0 0.0   EBITDA   122 92.8 -76.2 970 -439 609 0.0 0.0   EBIT   122 92.8 -76.2 970 -446 609 0.0 0.0   Pre-tax profit (PTP)   121.1 91.4 -77.6 964.2 -471.2 559.1 0.0 0.0   Net earnings   93.3 69.5 -62.3 751.1 -471.2 539.8 0.0 0.0   Pre-tax profit without non-rec. items   121 91.4 -77.6 964 -471 559 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 1,394 1,395 0.0 0.0   Shareholders equity total   176 153 90.9 786 257 715 574 574   Interest-bearing liabilities   0.0 0.0 0.0 61.5 697 731 0.0 0.0   Balance sheet total (assets)   310 283 321 1,403 1,815 1,790 574 574   Net Debt   -51.5 -59.8 -18.6 -832 362 658 -574 -574     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,847 1,688 1,011 2,332 823 1,817 0.0 0.0   Gross profit growth   119.1% -8.6% -40.1% 130.8% -64.7% 120.8% -100.0% 0.0%   Employees   0 0 0 3 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 -1,208.0 0.0 0.0   Balance sheet total (assets)   310 283 321 1,403 1,815 1,790 574 574   Balance sheet change%   84.4% -8.5% 13.2% 337.7% 29.4% -1.3% -67.9% 0.0%   Added value   121.6 92.8 -76.2 969.9 -446.1 1,817.4 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 1,386 1 -1,395 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.6% 5.5% -7.5% 41.6% -54.2% 33.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   50.9% 31.3% -25.2% 112.6% -27.1% 34.3% 0.0% 0.0%   ROI %   94.2% 56.4% -62.4% 206.8% -48.3% 51.5% 0.0% 0.0%   ROE %   72.2% 42.3% -51.0% 171.4% -90.4% 111.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   56.8% 54.1% 28.4% 56.0% 14.2% 40.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -42.3% -64.4% 24.4% -85.7% -82.6% 108.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 7.8% 271.1% 102.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 18.6% 9.5% 8.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 2.2 1.4 2.3 0.5 1.0 0.0 0.0   Current Ratio   2.3 2.2 1.4 2.3 0.5 1.0 0.0 0.0   Cash and cash equivalent   51.5 59.8 18.6 893.0 334.7 72.6 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   175.8 153.3 90.9 782.1 -442.9 17.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 323 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 323 0 0 0 0   EBIT / employee   0 0 0 323 0 0 0 0   Net earnings / employee   0 0 0 250 0 0 0 0